Cell and gene therapy CDMO Andelyn Biosciences celebrates over 20 years of leadership and innovation with opening of new 180,000 square foot manufacturing headquarters

Bridge­Bio shares longer-term PhII da­ta in limb-gir­dle: Bridge­Bio said that pa­tients with limb-gir­dle mus­cu­lar dy­s­tro­phy type 2I/R9 treat­ed with BBP-418 saw “sta­bi­liza­tion in NSAD scores

Known­well, the An­dreessen Horowitz and Flare Cap­i­tal Part­ners-backed meta­bol­ic health and pri­ma­ry care start­up, is adding six lo­ca­tions in the Chica­go area. It’s the lat­est

A 2016 class ac­tion law­suit filed against Alex­ion claim­ing shady sales prac­tices caused a de­cline in stock price could be near­ing its end af­ter both